Cargando…
Impact of ascorbic acid in reducing the incidence of vancomycin associated nephrotoxicity in critically ill patients: A preliminary randomized controlled trial
Background Antioxidants show nephroprotective effect against vancomycin associated nephrotoxicity (VAN) in animals. This study aimed to assess the ascorbic acid nephro-protective role against VAN clinically. Methods Forty-one critically ill patients were randomly assigned to one of two groups: inter...
Autores principales: | Hesham El-Sherazy, Nouran, Samir Bazan, Naglaa, Mahmoud Shaheen, Sara, A. Sabri, Nagwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479849/ https://www.ncbi.nlm.nih.gov/pubmed/34621519 http://dx.doi.org/10.12688/f1000research.55619.1 |
Ejemplares similares
-
Extended infusion of piperacillin–tazobactam versus intermittent infusion in critically ill egyptian patients: a cost-effectiveness study
por: Naiim, Christina Medhat, et al.
Publicado: (2022) -
The Nephrotoxicity of Vancomycin
por: Filippone, EJ, et al.
Publicado: (2017) -
Incidence and Predisposing Factors of Vancomycin-Induced Nephrotoxicity in Children
por: Ragab, Ahmed R., et al.
Publicado: (2013) -
Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity prediction using individualized pharmacokinetic parameters
por: Ghasemiyeh, Parisa, et al.
Publicado: (2022) -
Vancomycin-Associated Tubular Casts and Vancomycin Nephrotoxicity
por: Tantranont, Ngoentra, et al.
Publicado: (2021)